# DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

> **NCT02131324** · PHASE2 · COMPLETED · sponsor: **Promius Pharma, LLC** · enrollment: 50 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** DFD06 Cream
- **DRUG:** Clobetasol Propionate Cream 0.05%

## Key facts

- **NCT ID:** NCT02131324
- **Lead sponsor:** Promius Pharma, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-08-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02131324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02131324, "DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02131324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*